Zobrazeno 1 - 4
of 4
pro vyhledávání: ''
Autor:
Clara N Lee, Matthew H Wetschler, Yuchiao Chang, Jeffrey K Belkora, Beverly Moy, Ann Partridge, Karen R Sepucha
Publikováno v:
BMC Medical Informatics and Decision Making
Background Women diagnosed with early stage (I or II) breast cancer face a highly challenging decision – whether or not to undergo adjuvant chemotherapy. We developed a decision quality instrument for chemotherapy for early stage breast cancer and
Publikováno v:
BMC Medical Informatics and Decision Making
Background Breast cancer is one of the most critical cancers and is a major cause of cancer death among women. It is essential to know the survivability of the patients in order to ease the decision making process regarding medical treatment and fina
Publikováno v:
BMC Medical Informatics and Decision Making
Prosperi, M C F, Ingham, S L, Howell, A, Lalloo, F, Buchan, I E & Evans, D G 2014, ' Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment? ', BMC Medical Informatics and Decision Making, vol. 14, no. 1, 87 . https://doi.org/10.1186/1472-6947-14-87, https://doi.org/10.1186/1472-6947-14-87
Prosperi, M C F, Ingham, S L, Howell, A, Lalloo, F, Buchan, I E & Evans, D G 2014, ' Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment? ', BMC Medical Informatics and Decision Making, vol. 14, no. 1, 87 . https://doi.org/10.1186/1472-6947-14-87, https://doi.org/10.1186/1472-6947-14-87
© 2014 Prosperi et al.; licensee BioMed Central Ltd.Background: Several single nucleotide polymorphisms (SNPs) at different loci have been associated with breast cancer susceptibility, accounting for around 10% of the familial component. Recent stud
Autor:
Karen Collins, Malcolm W.R. Reed, Lynda Wyld, Jana Witt, Kate Lifford, Adrian Edwards, Maria Burton, Lisa Caldon, Katherine Emma Brain
Publikováno v:
BMC Medical Informatics and Decision Making
Background: Primary endocrine therapy (PET) is a recognised alternative to surgery followed by endocrine therapy for a subset of older women with breast cancer. Choice of treatment is therefore preference sensitive and may require decision support. T